Detalhe da pesquisa
1.
Prognostic impact of histological discordance between transurethral resection and radical cystectomy.
BJU Int
; 2024 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38344879
2.
Extracellular vesicles as novel uro-oncology biomarkers: insights toward clinical applications.
Curr Opin Urol
; 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38835180
3.
Association between comorbidities and survival in patients with metastatic urothelial carcinoma treated with pembrolizumab.
Int J Clin Oncol
; 29(5): 612-619, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38430304
4.
Effectiveness and safety of enzalutamide and apalutamide in the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC): a multicenter retrospective study.
Int J Clin Oncol
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38769191
5.
Real-world outcomes of adjuvant immunotherapy candidates with upper tract urothelial carcinoma: results of a multicenter cohort study.
Int J Clin Oncol
; 29(1): 55-63, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37863996
6.
Prostate cancer and liquid biopsies: Clinical applications and challenges.
Int J Urol
; 31(6): 617-626, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551314
7.
Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort study.
Int J Urol
; 31(2): 125-132, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37828777
8.
Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial carcinoma: A systematic review and network meta-analysis.
Int J Urol
; 31(1): 25-31, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37840031
9.
Oncological outcomes of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: A nationwide multi-institutional study.
Int J Urol
; 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38822533
10.
The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter study.
Int J Urol
; 31(4): 394-401, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38151321
11.
Long-term outcomes of radical prostatectomy versus low-dose-rate brachytherapy in patients with intermediate-risk prostate cancer: Propensity score matched comparison.
Prostate
; 83(2): 135-141, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36176043
12.
Effectiveness of pembrolizumab in trial-ineligible patients with metastatic urothelial carcinoma.
Cancer Immunol Immunother
; 72(4): 841-849, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36102985
13.
En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity Score-Matched Analysis.
Ann Surg Oncol
; 30(6): 3820-3828, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36897417
14.
Predicting Objective Response of Pembrolizumab in Platinum-Refractory Urothelial Carcinoma Based on NLR Fluctuation and Liver Metastases.
Oncology
; 2023 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37839399
15.
Re-challenging chemotherapy after pembrolizumab in platinum-refractory urothelial carcinoma.
BJU Int
; 131(4): 477-485, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36098556
16.
Comparison of neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma in real-world practice: a multicenter retrospective study.
Jpn J Clin Oncol
; 53(12): 1208-1214, 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37647644
17.
Comparison of outcomes in high-risk prostate cancer patients treated with low-/high-dose-rate brachytherapy plus external beam radiotherapy.
Int J Clin Oncol
; 28(5): 698-706, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36814038
18.
The prognostic significance of the clinical T stage and Grade Group in patients with locally advanced prostate cancer treated via high-dose-rate brachytherapy and external beam radiation.
Int J Clin Oncol
; 28(8): 1092-1100, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37227547
19.
Clinical characteristics of secondary bladder cancer developing after low-/high-dose-rate brachytherapy to treat localized prostate cancer.
Int J Clin Oncol
; 28(9): 1200-1206, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37432614
20.
Patients with PSA below 0.2 ng/mL at 8 years post high-dose-rate brachytherapy have an extremely low risk of subsequent recurrence.
Int J Urol
; 30(12): 1147-1154, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37650359